Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Square the circle

<< Previous

Bullboard Posts

Next >>

Comment by houbahopon Sep 26, 2023 11:25am

126 Views

Post# 35654569

RE:Square the circle

My expectations were not met.
No changes in the BoD, so it's business as usual.
I expect the stock to languish under $4 (or under $1 pre-consolidation).

I would not be surprised to see it trade under $2... pretty soon.
Who would have confidence in this pilot after this near death experience?

<< Previous

Bullboard Posts

Next >>

Sirios Resource discovers visible gold in Quebec